Chemokine Coreceptor-2 Gene Polymorphisms among HIV-1 Infected Individuals in Kenya

• Published in: Disease markers 2015-01, Vol.2015 (2015), p.1-4
• Main Authors: Maiyo, Alex, Okoth, Vincent, Lihana, Raphael, Wachira, Dorcas, Khamadi, Samoel Ashimosi
• Format: Article
• Language: English
• Subjects: Female; Gene Frequency; HIV Seropositivity - epidemiology; HIV Seropositivity - genetics; HIV-1; Humans; Kenya; Male; Mutation; Polymorphism, Restriction Fragment Length; Receptors, CCR2 - genetics
• ISSN: 0278-0240; 1875-8630
• DOI: 10.1155/2015/952067

Chemokine Coreceptor-2 (CCR2) is an entry coreceptor for HIV-1. A mutation in the coding gene for this coreceptor, CCR2-64I, has been shown to be an important factor for delaying disease progression. In Kenya no studies have been done to determine the status of CCR2 gene polymorphisms among HIV-1 infected individuals. To determine the existence and distribution of CCR2 gene mutations and identify polymorphic groups of the coreceptor gene in the population, a cross-sectional study was conducted to analyze the differences in allelic frequencies of CCR2-64I among HIV-1 seropositive individuals. Blood samples were collected from HIV/AIDS screening centers and analyzed for the presence of CCR2-64I using restriction fragment length polymorphism (RFLP). One hundred and eighteen samples collected from different regions of the country were genotyped for the CCR2-64I mutation. Of these, 4 (3.4%) were homozygous mutants (I/I) and 21 (17.8%) were heterozygous (V/I). Ninety-three subjects (78.8%) were wild type (V/V). With the search for a preventive/therapeutic HIV vaccine elusive, the presence of CCR-2 gene polymorphisms that delay disease progression and prolong the lives of the infected in the Kenyan population may contribute to the growing evidence that host genetic factors are important in predicting susceptibility to HIV-1 infection.